Tommy Andersson1, Anders Magnuson2, Ing-Liss Bryngelsson3, Ole Frøbert1, Karin M Henriksson4, Nils Edvardsson5, Dritan Poçi1. 1. Department of Cardiology, School of Medical Sciences, Örebro University, Örebro, Sweden. 2. Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden. 3. Department of Occupational and Environmental Medicine, School of Medical Sciences, Örebro University, Örebro, Sweden. 4. Department of Medical Science, Uppsala University, Uppsala and AstraZeneca R&D, Mölndal, Sweden. 5. Sahlgrenska Academy at Sahlgrenska University Hospital, Göteborg, Sweden.
Abstract
BACKGROUND: Little is known about the long-term, cause-specific mortality risk in patients without comorbidities at the time of diagnosis of atrial fibrillation (AF). METHODS: From a nation-wide registry of patients hospitalized with incident AF between 1995 and 2008 we identified 9 519 patients with a first diagnosed AF and no comorbidities at the time of AF diagnosis. They were matched with 12 468 controls. The follow-up continued until December 2008. Causes of death were classified according to the ICD-10 codes. RESULTS: During follow-up, 11.1% of patients with AF and 8.3% of controls died. Cardiovascular diseases were the most common causes of death and the only diagnoses which showed significantly higher relative risk in patients with AF than controls (HR 2.0, 95% CI 1.8-2.3), and the relative risk was significantly higher in women than in men. Stroke was a more common cause among patients with AF, 13.1% versus 9.7% (HR 2.7, 95% CI 1.8-4.0), while cerebral hemorrhage was more common among controls, 4.7% versus 10.2% (HR 0.9, 95% CI 0.6-1.5). The time from AF diagnosis to death was 6.0 ± 3.1 years. CONCLUSIONS: In patients with incident AF and no known comorbidities at the time of AF diagnosis, only cardiovascular diseases were more often causes of death as compared to controls. Women carried a significantly higher relative risk than men.
BACKGROUND: Little is known about the long-term, cause-specific mortality risk in patients without comorbidities at the time of diagnosis of atrial fibrillation (AF). METHODS: From a nation-wide registry of patients hospitalized with incident AF between 1995 and 2008 we identified 9 519 patients with a first diagnosed AF and no comorbidities at the time of AF diagnosis. They were matched with 12 468 controls. The follow-up continued until December 2008. Causes of death were classified according to the ICD-10 codes. RESULTS: During follow-up, 11.1% of patients with AF and 8.3% of controls died. Cardiovascular diseases were the most common causes of death and the only diagnoses which showed significantly higher relative risk in patients with AF than controls (HR 2.0, 95% CI 1.8-2.3), and the relative risk was significantly higher in women than in men. Stroke was a more common cause among patients with AF, 13.1% versus 9.7% (HR 2.7, 95% CI 1.8-4.0), while cerebral hemorrhage was more common among controls, 4.7% versus 10.2% (HR 0.9, 95% CI 0.6-1.5). The time from AF diagnosis to death was 6.0 ± 3.1 years. CONCLUSIONS: In patients with incident AF and no known comorbidities at the time of AF diagnosis, only cardiovascular diseases were more often causes of death as compared to controls. Women carried a significantly higher relative risk than men.
Authors: Eloi Marijon; Jean-Yves Le Heuzey; Stuart Connolly; Sean Yang; Janice Pogue; Martina Brueckmann; John Eikelboom; Ellison Themeles; Michael Ezekowitz; Lars Wallentin; Salim Yusuf Journal: Circulation Date: 2013-09-09 Impact factor: 29.690
Authors: Patricia Jabre; Véronique L Roger; Mohammad H Murad; Alanna M Chamberlain; Larry Prokop; Frédéric Adnet; Xavier Jouven Journal: Circulation Date: 2011-04-04 Impact factor: 29.690
Authors: B Weijs; C B de Vos; R G Tieleman; F E C M Peeters; I Limantoro; A A Kroon; E C Cheriex; R Pisters; H J G M Crijns Journal: Europace Date: 2012-07-10 Impact factor: 5.214
Authors: Yoko Miyasaka; Marion E Barnes; Kent R Bailey; Stephen S Cha; Bernard J Gersh; James B Seward; Teresa S M Tsang Journal: J Am Coll Cardiol Date: 2007-02-16 Impact factor: 24.094
Authors: Lin Y Chen; Nona Sotoodehnia; Petra Bůžková; Faye L Lopez; Laura M Yee; Susan R Heckbert; Ronald Prineas; Elsayed Z Soliman; Selcuk Adabag; Suma Konety; Aaron R Folsom; David Siscovick; Alvaro Alonso Journal: JAMA Intern Med Date: 2013-01-14 Impact factor: 21.873
Authors: Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson Journal: BMC Public Health Date: 2011-06-09 Impact factor: 3.295
Authors: Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi Journal: Eur Heart J Date: 2013-01-14 Impact factor: 29.983